Validation of Risk Models for Predicting Febrile Neutropenia Among Breast Cancer Patients Receiving Chemotherapy: A Real-World Study.

MLA

Hsu, Shu-Wei, et al. “Validation of Risk Models for Predicting Febrile Neutropenia Among Breast Cancer Patients Receiving Chemotherapy: A Real-World Study.” Clinical Therapeutics, Dec. 2024. EBSCOhost, https://doi.org/10.1016/j.clinthera.2024.11.011.

APA

Hsu, S.-W., Chiang, S.-C., Hsu, J. C., & Ko, Y. (2024). Validation of Risk Models for Predicting Febrile Neutropenia Among Breast Cancer Patients Receiving Chemotherapy: A Real-World Study. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2024.11.011

Chicago

Hsu, Shu-Wei, Shao-Chin Chiang, Jason C Hsu, and Yu Ko. 2024. “Validation of Risk Models for Predicting Febrile Neutropenia Among Breast Cancer Patients Receiving Chemotherapy: A Real-World Study.” Clinical Therapeutics, December. doi:10.1016/j.clinthera.2024.11.011.